Ascent Diagnostics
Revolutionizing OBGYN and Molecular PCR Testing
Ascent Diagnostics stands as a premier provider
specializingin the development of physician-owned
laboratories. With a seasoned team committed to
advancing healthcare diagnostics, we bring unpar
-lleled expertise to the field.
Resgistration Now!
Ascent Diagnostics
Revolutionizing OBGYN and Molecular PCR Testing
Play Video
Why Opt for Molecular PCR Testing inside your Urology practice?
- Enhanced Patient Outcomes: Comprehensive Urology Testing: Our molecular PCR testing for UTIs delivers detailed insights, enabling accurate diagnoses for improved patient care.
- Early Detection: Uncover potential urological health issues early, allowing proactive intervention and elevated patient care.
- Financial Benefits: Maximize Revenue: Experience a significant net gain per test performed, enhancing the financial health of your Urology practice.
Additional Advantages
- Enhanced Patient Outcomes: Our team provides comprehensive training on billing procedures, ensuring seamless financial management.
- Validation Teams: Positioned to validate the technology for optimal performance.
- Logistics Management: We efficiently manage all logistics for sample collection.
- EHR Integration: Seamlessly integrate with the Electronic Health Record system for smooth data transmission and reception.
Ascent Diagnostics: Revolutionizing OBGYN & Molecular PCR Testing
Ascent Diagnostics stands as a premier provider specializing in the development of physician owned laboratories. With a seasoned team committed to advancing healthcare diagnostics, we bring unparalleled expertise to the field.
Why Opt for Molecular PCR Testing inside your practice?
Enhanced Patient Outcomes
- Comprehensive OBGYN Testing: Our molecular PCR testing for UTI, Vaginitis, and STIs delivers detailed insights, enabling accurate diagnoses for improved patient care.
- Early Detection: Uncover potential reproductive health issues early, allowing proactive intervention and elevated patient care.
Financial Benefits
- Maximize Revenue: Experience a significant net gain per test performed, enhancing the financial health of your OBGYN practice.
Primary Objective
The STOP-Cancer Clinical Trial is a study that will evaluate the clinical benefit of using genetics to assess overall hereditary genetic cancer risk and help pursue preventative measures which may lead to early detection and treatment of the “cancer condition”. This is an observational research study, in which you will collect data to achieve the following objectives:
Objectives
- Observe and Record data over the 120 day observation period.
- Evaluate the clinical benefit of using hereditary cancer genomic diagnostics, to assess the overall hereditary genetic cancer risk profile.
- Help guide physicians to pursue preventative measures which may lead to early detection and treatment of the condition (non-medication treatments such as diet, nutrition, exercise, rest, sleep, stress reduction, smoking cessation programs, psychosocial & risk assessment counseling, etc).
We would like to invite you to participate in the Hereditary Cancer Clinical Trial!
( STOP-CANCER” Strategic Targeting for Optimal Prevention of Cancer)
Frequently Ask Questions
We are excited to offer your site the opportunity to participate in this Clinical Trial.
If you are interested in learning more, please do not hesitate to contact one of our
Representatives to set up a conference call.
No, this trial is suitable for all levels of experience or none at all.
Cancer Genetic Testing is collected by using a saliva buccal swab of the cheek squamous cells.
Breast, Ovarian, Colorectal, Pancreatic, Endometrial, Prostate, Gastric, Lynch, Uterine, Renal, Liver, Melanoma
Yes, we offer a $225 honorarium per completed CRF.
The protocol is available upon request.
- Copyright © 2024 Medical Healthcare. All rights reserved.